Skip to main content
. 2024 Mar 28;47(9):2213–2224. doi: 10.1007/s40618-024-02348-9

Fig. 2.

Fig. 2

Receiver operating characteristic (ROC) curves for initial NBS-TSH level, initial serum TSH level, and LT4 dose at withdrawal, for predicting TCH (A). ROC curves for LT4 dose at withdrawal, for predicting eutopic TCH (B)